Image

Impact of 4PCP on Practitioner and Patient Outcomes

Impact of 4PCP on Practitioner and Patient Outcomes

Recruiting
14-80 years
All
Phase N/A

Powered by AI

Overview

Reducing opioid prescribing and improving outcomes in patients with chronic pain would benefit our nation. Neither addiction nor chronic pain spares any race, gender, or particular socio-economic status. This study is investigating a potentially inexpensive way of providing a previously costly service (the intensive chronic pain rehabilitation program), which is why insurers stopped covering it. Although it is unusual for an application from an academic institution to include a startup company (PainSTakers, LLC) as the curriculum provider, this is actually a long-term strength of this program, and the reason NIH recommended this route. It ensures that 4PCP will ultimately sustain itself rather than require government support for its continuation. Support for this application is not to provide the curriculum, but to determine if it is effective in the outcomes expected to be found. The curriculum is being provided freely only as an incentive for practitioners to participate in the research portion of the study. If the study is able to demonstrate its clinical effectiveness, the next step will be to show a positive economic impact for health care institutions and for health insurers who may then wish to support the program for their practitioners and their patients.

Description

Practitioner procedures:

After the completion of informed consent, practitioners will be sent their first set of surveys (Baseline).

1 week before the first day of the practitioner's course, they will be sent a second set of surveys (Time 0).

6 months after course completion, practitioners will be sent their next set of surveys (Follow Up 1).

6 months after the distribution of Follow Up Survey 1, practitioners will be sent their next set of surveys (Follow Up 2).

6 months after the distribution of Follow Up Survey 2, practitioners will be sent their next set of surveys (Follow Up 3).

6 months after the distribution of Follow Up Survey 3, practitioners will be sent their final set of surveys (Follow Up 4).

Patient procedures:

After the completion of informed consent, patients will be sent their first set of surveys (Baseline).

1 week before the first day of the patient's practitioner's course, they will be sent a second set of surveys (Time 0).

6 months after their practitioner's course completion, patients will be sent their next set of surveys (Follow Up 1).

6 months after the distribution of Follow Up Survey 1, patients will be sent their next set of surveys (Follow Up 2).

6 months after the distribution of Follow Up Survey 2, patients will be sent their next set of surveys (Follow Up 3).

6 months after the distribution of Follow Up Survey 3, patients will be sent their final set of surveys (Follow Up 4).

Practitioner measures:

  • Demographics
  • HC-PAIRS
  • Mini Z & Burnout
  • PABS-PT
  • Skills Comparison
  • Multi-Disc Perspective Questionnaire
  • CPPP (for MDs/DOs)
  • Know Pain-12

Patient measures:

  • Demographics
  • Medication information
  • PEG-3
  • PCS
  • PROMIS 8A
  • PROMIS Global Health
  • PROMIS Pain Interference
  • GAD-7
  • PHQ-8
  • Secondary measures abstracted from state prescribing records

Practitioner interventions:

4PCP training course

Patient interventions:

No direct interventions, but concepts practitioners learn from the 4PCP curriculum may change the way the practitioner continues care with the patient.

Eligibility

Practitioner Inclusion:

  • General practitioners
  • Part of a practice that has their own identifiable patient population including patients with chronic pain
  • Able to fully answer questionnaires
  • Able to attend 4PCP course
  • English speaking

Patient inclusion:

  • Age 14-80
  • Self-report of chronic non-malignant pain > 3 months
  • No foreseeable or planned surgeries for chronic pain
  • Has attended at least 2 established visits in the enrolled practitioner's practice
  • English speaking

Practitioner exclusion:

  • Pain specialists
  • Unable to fully answer questionnaires
  • Unable to attend the 4PCP course
  • Non-English speaking

Patient exclusion:

  • Unable to answer questionnaires (e.g. stroke, dementia, developmental delay, etc.)
  • Followed in a specialty pain clinic (PCP not managing pain care)
  • Sickle cell disease
  • Prisoners
  • Non-English speaking

Study details
    Chronic Pain

NCT05580419

Virginia Commonwealth University

24 July 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.